aTyr Pharma, Inc. ATYR
3.69 USD -0.39 (-9.56%)
Regular-session close
3.70 +0.01 +0.27%
After hours · Nov 19, 4:12 PM ET
3.69 Day range 4.21
3.69 52-week range 44.40
- YTD
- -88.22%
- 1 year
- -86.33%
Analyst view
Consensus: buy
Buy
Price target (mean) 21.29 +476.8% upside
Now 3.69
- Target (low)
- 9.00
- Target (mean)
- 21.29
- Target (high)
- 35.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy4
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 7
- 2 months ago 7
- 3 months ago 6
Included in Essentials and up
Sign in to see Revenue and earnings forecast
Reported revenue and earnings per share by year, then what analysts expect next.
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.23286 | -0.25 – -0.22 | -0.25 | +6.9% | 0 | 0.0% | 7 |
| Next quarter | -0.245 | -0.25 – -0.24 | -0.23 | -6.5% | 0 | -100.0% | 2 |
| Current year | -0.91857 | -0.95 – -0.90 | -0.94 | +2.3% | 178.33K | -49.5% | 7 |
| Next year | -0.81143 | -0.98 – -0.65 | -0.91857 | +11.7% | 3.53M | +1877.6% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 10, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 4, 2024 | Wells Fargo | Initiated | — | Overweight |
| Sep 5, 2024 | Jefferies | Initiated | — | Buy |
| Aug 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 14, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 15, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
Included in Plus and up
Sign in to see Analyst trend
Two years of the analyst rating mix and the average price target against the price.
